These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29360794)

  • 1. Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.
    Fujimura T; Takayama K; Takahashi S; Inoue S
    Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29360794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues.
    Cheung CP; Yu S; Wong KB; Chan LW; Lai FM; Wang X; Suetsugi M; Chen S; Chan FL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1830-44. PubMed ID: 15598686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
    Fizazi K; Smith MR; Tombal B
    Clin Genitourin Cancer; 2018 Oct; 16(5):332-340. PubMed ID: 30197098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer.
    Sinha AA; Pomroy FE; Wilson MJ
    Anticancer Res; 2016 Aug; 36(8):3847-54. PubMed ID: 27466486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.
    Izumi K; Mizokami A
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches.
    Jefferi NES; Shamhari A'; Noor Azhar NKZ; Shin JGY; Kharir NAM; Azhar MA; Hamid ZA; Budin SB; Taib IS
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
    Shore ND; Antonarakis ES; Cookson MS; Crawford ED; Morgans AK; Albala DM; Hafron J; Harris RG; Saltzstein D; Brown GA; Henderson J; Lowentritt B; Spier JM; Concepcion R
    Prostate; 2020 May; 80(6):527-544. PubMed ID: 32130741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
    Linder A; Larsson K; Welén K; Damber JE
    Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer.
    Golabek T; Belsey J; Drewa T; Kołodziej A; Skoneczna I; Milecki P; Dobruch J; Słojewski M; Chłosta PL
    Cent European J Urol; 2016; 69(2):131-8. PubMed ID: 27551549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting androgen-independent pathways: new chances for patients with prostate cancer?
    Cattrini C; Zanardi E; Vallome G; Cavo A; Cerbone L; Di Meglio A; Fabbroni C; Latocca MM; Rizzo F; Messina C; Rubagotti A; Barboro P; Boccardo F
    Crit Rev Oncol Hematol; 2017 Oct; 118():42-53. PubMed ID: 28917268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer.
    Ojo D; Lin X; Wong N; Gu Y; Tang D
    Cancers (Basel); 2015 Nov; 7(4):2290-308. PubMed ID: 26593949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer.
    Di Zazzo E; Galasso G; Giovannelli P; Di Donato M; Bilancio A; Perillo B; Sinisi AA; Migliaccio A; Castoria G
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31548498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H
    Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling.
    Wu J; Sun H; Yang X; Sun X
    Clin Transl Oncol; 2018 Oct; 20(10):1302-1313. PubMed ID: 29594945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further.
    Fujimoto N
    J UOEH; 2016 Jun; 38(2):129-38. PubMed ID: 27302726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.